Alessandro Re
Brescia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 117 publications
Study of brentuximab vedotin combination treatment in people with early-stage Hodgkin lymphoma: a plain language summary.
Journal: Future oncology (London, England)
Published: July 06, 2026
Summary of Research: Brentuximab Vedotin and Nivolumab in Combination with Chemotherapy for Nonbulky, Early-Stage Classical Hodgkin Lymphoma.
Journal: Advances in therapy
Published: May 08, 2026
Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi.
Journal: British journal of haematology
Published: April 22, 2026
The predictive and prognostic role of baseline 2-[18F]FDG PET/CT volumetric and dissemination features in classical Hodgkin lymphoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 21, 2026
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)-MCL0208 clinical trial.
Journal: HemaSphere
Published: October 10, 2025
Letter in response to "Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: a Delphi Consensus".
Journal: Cytotherapy
Published: September 21, 2025
Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53).
Journal: British journal of haematology
Published: July 24, 2025
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study.
Journal: The Lancet. Haematology
Published: April 28, 2025
Last Updated: 09/26/2026